Novel cationic transport agents for oligonucleotide delivery into primary leukemic cells

Journal of Medicinal Chemistry

Volumn 46, Issue 11, 2003, Pages 2049-2056

  Králová, Jarmila ^a   Dvořák, Michal ^a   Král, Vladimír ^b  

^a INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

^b INSTITUTE OF CHEMICAL TECHNOLOGY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CATION; DRUG CARRIER; PORPHYRIN DERIVATIVE;

ARTICLE; CANCER INHIBITION; CELL LINE; DRUG CYTOTOXICITY; DRUG DEGRADATION; DRUG SOLUBILITY; DRUG SYNTHESIS; GENE EXPRESSION; LEUKEMIA CELL; REPRODUCIBILITY;

ANIMALS; CELL LINE, TRANSFORMED; CHICKENS; DRUG CARRIERS; FLUORESCEIN-5-ISOTHIOCYANATE; GENE TRANSFER TECHNIQUES; LEUKEMIA; MICROSCOPY, FLUORESCENCE; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; ONCOGENE PROTEINS V-MYB; PORPHYRINS; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 0037911370     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm021060d     Document Type: Article

References (30)

1. Juliano, R. L.; Alahari, S.; Yoo, H.; Kole, R.; Cho, M. Antisense pharmacodynamics: critical issues in the transport and delivery of antisense oligonucleotides. Pharm. Res. 1999, 16, 494-502.
2. Hughes, J.; Astriab, A.; Yoo, H.; Alahari, S.; Liang, E.; Sergueev, D.; Shaw, B. R.; Juliano, R. L. In vitro transport and delivery of antisense oligonucleotides. Methods Enzymol. 2000, 313, 342-58.
3. Dokka, S.; Rojanasakul, Y. Novel non-endocytic delivery of antisense oligonucleotides. Adv. Drug Delivery Rev. 2000, 44, 35-49.
4. Garcia-Chaumont, C.; Seksek, O.; Grzybowska, J.; Borowski, E.; Bolard, J. Delivery systems for antisense oligonucleotides. Pharmacol. Ther. 2000, 87, 255-277.
5. Lebedeva, I.; Benimetskaya, L.; Stein, C. A.; Vilenchik, M. Cellular delivery of antisense oligonucleotides. Eur. J. Pharm. Biopharm. 2000, 50, 101-119.
6. Dass, C. R. Vehicles for oligonucleotide delivery to tumours. J. Pharm. Pharmacol. 2002, 54, 3-27.
7. Manoharan, M. Oligonucleotide conjugates as potential antisense drugs with improved uptake, biodistribution, targeted delivery and mechanism of action. Antisense Nucleic Acid Drug Dev. 2002, 12, 103-128.
8. Lewis, J. G.; Lin, K. Y.; Kothavale, A.; Flanagan, W. M.; Matteucci, M. D.; DePrince, R. B.; Mook, R. A.; Hendren, R. W.; Wagner, R. W. A serum-resistant cytofectin for cellular delivery of antisense oligodeoxynucleotides and plasmid DNA. Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 3176-3181.
9. Marcusson, E. G.; Bhat, B.; Manoharan, M.; Bennett, C. F.; Dean, N. M. Phosphorothioate oligodeoxyribonucleotides dissociate from cationic lipids before entering the nucleus. Nucleic Acids Res. 1998, 26, 2016-2023.
10. Spiller, D. G.; Giles, R. V.; Grzybowski, J.; Tidd, D. M.; Clark, R. E. Improving the intracellular delivery and molecular efficacy of antisense oligonucleotides in chronic myeloid leukemia cells: a comparison of streptolysin-O permeabilization, electroporation, and lipophilic conjugation. Blood 1998, 91, 4738-4746.
11. Benimetskaya, L.; Takle, G. B.; Vilenchik, M.; Lebedeva, I.; Miller, P.; Stein, C. A. Cationic porphyrins: novel delivery vehicles for antisense oligodeoxynucleotides. Nucleic Acids Res. 1998, 26, 5310-5317.
12. Flynn, S. M.; George, S. T.; White, L.; Devonish, W.; Takle, G. B. Water-soluble, meso-substituted cationic porphyrins - a family of compounds for cellular delivery of oligonucleotides. BioTechniques 1999, 26, 736-742.
13. Kubát, P.; Lang, K.; Anzenbacher, P., Jr.; Jursíková, K.; Král, V.; Ehrenberg, B. Interaction of novel cationic meso-tetraphenylporphiryns in the ground and excited states with DNA and nucleotides. J. Chem. Soc., Perkin Trans. 1 2000, 933-941.
14. Kral, V.; Furuta, H.; Shreder, K.; Lynch, V.; Sessler, J. L. Protonated sapphyrins. Highly effective phosphate receptors. J. Am. Chem. Soc. 1996, 118, 1595-1607.
15. Sessler, J. L.; Sansom, P. I.; Kral, V.; O'Connor, D.; Iverson, B. L. Sapphyrin-oligonucleotide conjugates. Novel sequence-specific DNA photomodifying agents with increased binding affinity. J. Am. Chem. Soc. 1996, 118, 12322-12330.
16. Iverson, B. L.; Shreder, K.; Kral, V.; Sansom, P.; Lynch, V.; Sessler, J. L. Interaction of sapphyrin with phosphorylated species of biological interest. J. Am. Chem. Soc. 1996, 118, 1608-1616.
17. Lang, K.; Anzenbacher, P.; Kapusta, P.; Král, V.; Kubát, P.; Wagnerová, D. M. Long-range assemblies on poly(dG-dC)2 and poly(dA-dT)2: phosphonium cationic porphyrins and the importance of the charge. J. Photochem. Photobiol., B 2000, 57, 51-59.
18. Frederic, M.; Scherman, D.; Byk, G. Introduction of cyclic guanidines into cationic lipids for non-viral gene delivery. Tetrahedron Lett. 2000, 41, 675-679.
19. Marmillon, C.; Bompart, J.; Calas, M.; Escale, R.; Bonnet, P. A. Solution parallel synthesis of cyclic guanidines. Heterocycles 2000, 53, 1317-1328.
20. Kral, V.; Schmidtchen, F. P.; Lang, K.; Berger, M. Anion-controlled assembly of porphyrin-bicyclic guanidine conjugates. Org. Lett. 2002, 4, 51-54.
21. Berger, M.; Schmidtchen, F. P. Zwitterionic guanidinium compounds serve as electroneutral anion hosts. J. Am. Chem. Soc. 1999, 121, 9986-9993.
22. Schmuck, C. Carboxylate binding by 2-(guanidiniocarbonyl)-pyrrole receptors in aqueous solvents: Improving the binding properties of guanidinium cations through additional hydrogen bonds. Chemistry, 2000, 6, 709-718.
23. Kral, V.; Davis, J.; Andrievsky, A.; Kralova, J.; Synytsya, A.; Pouckova, P.; Sessler, J. L. Synthesis and biolocalization of water-soluble sapphyrins. J. Med. Chem. 2002, 45, 1073-1078.
24. Dvorakova, M.; Kralova, J.; Karafiat, V.; Bartunek, P.; Dvorak, M. An ex vivo model to study v-Myb-induced leukemogenicity. Blood Cells Mol. Dis. 2001, 27, 437-445.
25. Bartunek, P.; Karafiat, V.; Dvorakova, M.; Zahorova, V.; Mandikova, S.; Zenke, M.; Dvorak, M. The Myb leucine zipper is essential for leukemogenicity of the v-Myb protein. Oncogene 1997, 15, 2939-2949.
26. Moscovici, C. Leukemic transformation with avian myeloblastosis virus: present status. Curr. Top. Microbiol. Immunol. 1975, 71, 79-101.
27. Sambrook, J.; Fritsch, E. F.; Maniatis, T. Molecular Cloning: A Laboratory Manual; Cold Spring Harbor Laboratory Press: Spring Harbor, NY, 1989.
28. Kronenwett, R.; Steidl, U.; Kirsch, M.; Sczakiel, G.; Haas, R. Oligodeoxyribonucleotide uptake in primary human hematopoietic cells is enhanced by cationic lipids and depends on the hematopoietic cell subset. Blood 1998, 91, 852-862.
29. Dyer, R. B.; Herzog, N. K. Isolation of intact nuclei for nuclear extract preparation from a fragile B-lymphocyte cell line. BioTechniques 1995, 19, 192-195.
30. Kubát, P.; Lang, K.; Král, V.; Anzenbacher, P., Jr. Preprogramming of porphyrin-nucleic acids assemblies via variation of the alkyl/aryl substituents of phospohonium tetratolylporphyrins. J. Chem. Phys. B 2002, 106, 6784-6792.